跳至主要内容
临床试验/NL-OMON31107
NL-OMON31107尚未招募4 期

Treatment of dumping syndrome with Lanreotide Autogel - TDLA

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Dumping provocation test positive
  • Dumping symptoms devised by Sigstad
  • Patients with late dumping are selected by postprandial hypoglycaemie plasma glucose <3.0 after 60 min after ingestion of 50 g glucose/m2 body surface and hypoglycaemic symptoms at least 60 min after the oral glucose load.
  • Patients who have long term octreotide LAR therapy
  • Age 18 years or older
  • Informed consent

排除标准

  • Patients with disorders of endocrine system
  • Patients with severe kidney , liver, cardiovascular disease.
  • Patients who are pregnant or giving breast feeding
  • Patinets with recent gastrointestinal surgery or other gastrointestinal diseases

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验